| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |